SplitJun 17, 2026, 11:51 AM
Lakewood-Amedex Announces 1-for-10 Reverse Stock Split
AI Summary
Lakewood-Amedex Biotherapeutics Inc. announced a 1-for-10 reverse stock split of its common stock, effective June 19, 2026. The company's shares will begin trading on a split-adjusted basis on Nasdaq on June 22, 2026. This action will reduce the number of outstanding shares and proportionately adjust authorized shares and equity awards.
Key Highlights
- Lakewood-Amedex Biotherapeutics Inc. filed a Certificate of Change for a 1-for-10 reverse stock split.
- The reverse stock split will become effective at 4:01 p.m. ET on June 19, 2026.
- Common Stock will begin trading on a split-adjusted basis on Nasdaq on June 22, 2026.
- The split will reduce outstanding shares from approximately 17,506,577 million to 1,750,789 million.
- Authorized shares of Common Stock will be proportionately reduced to 12,500,000.
- The company's Common Stock will continue to trade under the symbol "LABT" with a new CUSIP number (51255A201).
Price Impact
More from LABT